News|Videos|November 18, 2026

Treatment of Repetitive Behaviors in Autism: Where Does the Evidence Stand?

Restricted repetitive behaviors in autism were distinguished by the child’s inner experience, and focused behavioral intervention carried the clearest treatment evidence.

Distinguishing restricted repetitive behaviors (RRBs) in autism from obsessive-compulsive disorder (OCD) and tics is often based on the child’s inner experience, shared Gaelle Rached, MD. Unlike OCD where obsessions were intrusive and anxiety provoking, with compulsions performed to neutralize the anxiety, autism-related RRBs were calming and preferred, and distress emerged when they were blocked rather than during engagement. Tics were sudden, rapid, and nonrhythmic, followed a premonitory urge that waxed and waned, and could be briefly suppressed. Motor stereotypies in autism tended to be rhythmic, occurred during excitement or absorption, and usually stopped with distraction without a premonitory urge. The lines blurred with insistence on sameness, and comorbid OCD and autism complicated differentiation.

Pharmacologic evidence for treating RRBs in autism was limited, Rached highlighted. A review of more than 100 trials testing dozens of medications yielded low confidence overall.¹ Second-generation antipsychotics such as risperidone and aripiprazole reduced RRBs, but the effect was small. Selective serotonin reuptake inhibitor trials were largely negative in children and adolescents, with more positive results in adults, possibly reflecting a developmental difference. Early results for N-acetylcysteine, neuroactive steroids, and transcranial magnetic stimulation were promising but very preliminary.

Focused behavioral intervention carried the clearest evidence and largest effects. Clinicians targeted 1 or more of the most troublesome behaviors using approaches such as functional communication training, which taught a child an alternative way to obtain what the behavior achieved, such as asking for a break. Parent-mediated approaches interrupted and redirected repetitive behaviors, and cognitive behavioral therapy with gradual exposure to change helped with insistence on sameness.² “The honest answer is that we have more options than strong evidence. And the best approach is as always to balance behavioral, psychosocial, and pharmacological treatment rather than picking one,” Rached said. She noted that “the goal isn’t to eliminate the behavior or the restricted repetitive behavior, but to treat the ones that really cause suffering or impairment.”

RRBs were understudied relative to social communication despite families often naming them as the most disruptive part of their lives. Rached advocated a dimensional approach that treated RRBs as a distinct domain with their own courses, along with better measurement to detect change in clinical trials, larger trials of psychosocial interventions in older children and adolescents, and studies of combination treatments, because most children benefit from more than 1 approach at a time.

Dr Rached is a child and adolescent psychiatry fellow at Lurie Children’s Hospitcal.

References

1. Yu Y, Chaulagain A, Pedersen SA, et al. Pharmacotherapy of restricted/repetitive behavior in autism spectrum disorder: a systematic review and meta-analysis. BMC Psychiatry. 2020;20(1):121.

2. Zarafshan H, Salmanian M, Aghamohammadi S, et al. Effectiveness of non-pharmacological interventions on stereotyped and repetitive behaviors in preschool children with autism: a systematic review. Basic Clin Neurosci. 2017;8(2):95-104.


Related to this article